https://www.selleckchem.com/pr....oducts/calcipotriene
001). Distress is at its peak prior to treatment onset and rapidly decreases once treatment has started. Oncologist should be aware that both completion of NACT and undergoing surgery are associated with increases in distress and Hispanic patients may be more at risk for an increase in distress at these times; this suggests that careful monitoring of distress during the treatment trajectory and in Hispanic patients in particular in order to provide timely support. Distress is at its peak prior to treatment onset and rapidly decrea
Like
Comment
Share
